Literature DB >> 17700530

A role for iron in Wnt signalling.

M J Brookes1, J Boult, K Roberts, B T Cooper, N A Hotchin, G Matthews, T Iqbal, C Tselepis.   

Abstract

There is an emerging body of evidence implicating iron in carcinogenesis and in particular colorectal cancer, but whether this involves Wnt signalling, a major oncogenic signalling pathway has not been studied. We aimed to determine the effect of iron loading on Wnt signalling using mutant APC (Caco-2 and SW480) and wild-type APC (HEK-293 and human primary fibroblasts) containing cell lines. Elevating cellular iron levels in Caco-2 and SW480 cells caused increased Wnt signalling as indicated by increased TOPFLASH reporter activity, increased mRNA expression of two known targets, c-myc and Nkd1, and increased cellular proliferation. In contrast wild-type APC and beta-catenin-containing lines, HEK 293 and human primary fibroblasts were not responsive to iron loading. This was verified in SW480 cells that no longer induced iron-mediated Wnt signalling when transfected with wild-type APC. The cell line LS174T, wild type for APC but mutant for beta-catenin, was also responsive suggesting that the role of iron is to regulate beta-catenin. Furthermore, we show that E-cadherin status has no influence on iron-mediated Wnt signalling. We thus speculate that excess iron could exacerbate tumorigenesis in the background of APC loss, a common finding in cancers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17700530     DOI: 10.1038/sj.onc.1210711

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  53 in total

1.  Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.

Authors:  Morgan E Preziosi; Sucha Singh; Erika V Valore; Grace Jung; Branimir Popovic; Minakshi Poddar; Shanmugam Nagarajan; Tomas Ganz; Satdarshan P Monga
Journal:  J Hepatol       Date:  2017-03-22       Impact factor: 25.083

Review 2.  Iron and Cancer.

Authors:  Suzy V Torti; David H Manz; Bibbin T Paul; Nicole Blanchette-Farra; Frank M Torti
Journal:  Annu Rev Nutr       Date:  2018-08-21       Impact factor: 11.848

3.  Iron chelation: a potential therapeutic strategy in oesophageal cancer.

Authors:  B D Keeler; M J Brookes
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

4.  IRP2 regulates breast tumor growth.

Authors:  Wei Wang; Zhiyong Deng; Heather Hatcher; Lance D Miller; Xiumin Di; Lia Tesfay; Guangchao Sui; Ralph B D'Agostino; Frank M Torti; Suzy V Torti
Journal:  Cancer Res       Date:  2013-11-27       Impact factor: 12.701

Review 5.  Iron, microbiota and colorectal cancer.

Authors:  Oliver Ng
Journal:  Wien Med Wochenschr       Date:  2016-08-30

6.  Preoperative iron status is a prognosis factor for stage II and III colorectal cancer.

Authors:  Hiroshi Sawayama; Yuji Miyamoto; Kosuke Mima; Rikako Kato; Katsuhiro Ogawa; Yukiharu Hiyoshi; Mototsugu Shimokawa; Takahiko Akiyama; Yuki Kiyozumi; Shiro Iwagami; Masaaki Iwatsuki; Yoshifumi Baba; Naoya Yoshida; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2021-07-23       Impact factor: 3.402

7.  Cadmium induces Wnt signaling to upregulate proliferation and survival genes in sub-confluent kidney proximal tubule cells.

Authors:  Prabir K Chakraborty; Wing-Kee Lee; Malte Molitor; Natascha A Wolff; Frank Thévenod
Journal:  Mol Cancer       Date:  2010-05-08       Impact factor: 27.401

Review 8.  Iron and cancer: more ore to be mined.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Nat Rev Cancer       Date:  2013-04-18       Impact factor: 60.716

9.  Heme-related gene expression signatures of meat intakes in lung cancer tissues.

Authors:  Tram Kim Lam; Melissa Rotunno; Brid M Ryan; Angela C Pesatori; Pier Alberto Bertazzi; Margaret Spitz; Neil E Caporaso; Maria Teresa Landi
Journal:  Mol Carcinog       Date:  2013-05-16       Impact factor: 4.784

10.  Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma.

Authors:  Takao Kamai; Naohisa Tomosugi; Hideyuki Abe; Kyoko Arai; Ken-Ichiro Yoshida
Journal:  BMC Cancer       Date:  2009-08-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.